Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Wnt signaling promotes oncogenic transformation by inhibiting c-Mycinduced apoptosis
Zongbing You1,
Daniel Saims1,
Shaoqiong Chen1,
Zhaocheng Zhang1,
Denis C. Guttridge5,
Kun-liang Guan2,3,
Ormond A. MacDougald2,4,
Anthony M.C. Brown6,
Gerard Evan7,
Jan Kitajewski8, and
Cun-Yu Wang1,2
1 Laboratory of Molecular Signaling and Apoptosis, Department of Biologic and Materials Sciences, School of Dentistry 2 Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI 48109 3 Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109 4 Department of Physiology, University of Michigan, Ann Arbor, MI 48109 5 Division of Human Genetics, Department of Medical Microbiology and Immunology, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210 6 Strang Cancer Research Laboratory, The Rockefeller University, and Department of Cell Biology and Anatomy, Weill Medical College of Cornell University, New York, NY 10021 7 Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143 8 Department of Pathology and Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY 10021
Address correspondence to Cun-Yu Wang, Laboratory of Molecular Signaling and Apoptosis, Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor, MI 48109-1078. Tel.: 734-615-4386. Fax: 734-764-2425. E-mail: cunywang{at}umich.edu
Abstract:
Aberrant activation of the Wnt/ß-catenin signalingpathway is associated with numerous human cancers and oftencorrelates with the overexpression or amplification of the c-myconcogene. Paradoxical to the cellular transformation potentialof c-Myc is its ability to also induce apoptosis. Using an induciblec-MycER expression system, we found that Wnt/ß-cateninsignaling suppressed apoptosis by inhibiting c-Mycinducedrelease of cytochrome c and caspase activation. Both cyclooxygenase2 and WISP-1 were identified as effectors of the Wnt-mediatedantiapoptotic signal. Soft agar assays showed that neither c-Mycnor Wnt-1 alone was sufficient to induce cellular transformation,but that Wnt and c-Myc coordinated in inducing transformation.Furthermore, coexpression of Wnt-1 and c-Myc induced high-frequencyand rapid tumor growth in nude mice. Extensive apoptotic bodieswere characteristic of c-Mycinduced tumors, but not tumorsinduced by coactivation of c-Myc and Wnt-1, indicating thatthe antiapoptotic function of Wnt-1 plays a critical role inthe synergetic action between c-Myc and Wnt-1. These resultselucidate the molecular mechanisms by which Wnt/ß-catenininhibits apoptosis and provide new insight into Wnt signaling-mediatedoncogenesis.
Targeting Renal Cancer with a Combination of WNT Inhibitors and a Bi-Functional Peptide.
C. M. KOLLER, Y. KIM, and I. G. H. SCHMIDT-WOLF (2013)
Anticancer Res
33, 2435-2440
|Abstract »|Full Text »|PDF »
Antagonistic Effect of Small-molecule Inhibitors of Wnt/{beta}-catenin in Multiple Myeloma.
B. A. NARAYANAN, N. A. DOUDICAN, J. PARK, D. XU, N. K. NARAYANAN, R. DASGUPTA, and A. MAZUMDER (2012)
Anticancer Res
32, 4697-4707
|Abstract »|Full Text »|PDF »
Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models.
Q. Zhang, S. Liu, D. Ge, Q. Zhang, Y. Xue, Z. Xiong, A. B. Abdel-Mageed, L. Myers, S. M. Hill, B. G. Rowan, et al. (2012)
Cancer Res.
72, 2589-2599
|Abstract »|Full Text »|PDF »
Activation of Wnt3a signaling stimulates intestinal epithelial repair by promoting c-Myc-regulated gene expression.
L. Liu, J. N. Rao, T. Zou, L. Xiao, A. Smith, R. Zhuang, D. J. Turner, and J.-Y. Wang (2012)
Am J Physiol Cell Physiol
302, C277-C285
|Abstract »|Full Text »|PDF »
Targeting the Wnt/Beta-catenin Pathway with the Antifungal Agent Ciclopirox Olamine in a Murine Myeloma Model.
Y. KIM, M. SCHMIDT, T. ENDO, D. LU, D. CARSON, and I. G. H. SCHMIDT-WOLF (2011)
In Vivo
25, 887-893
|Abstract »|Full Text »|PDF »
Genome-Wide Analysis of a Wnt1-Regulated Transcriptional Network Implicates Neurodegenerative Pathways.
E. M. Wexler, E. Rosen, D. Lu, G. E. Osborn, E. Martin, H. Raybould, and D. H. Geschwind (2011)
Science Signaling
4, ra65
|Abstract »|Full Text »|PDF »
Increased In vivo Efficacy of Lenalidomide and Thalidomide by Addition of Ethacrynic Acid.
M. SCHMIDT, Y. KIM, S.-M. GAST, T. ENDO, D. LU, D. CARSON, and I. G. H. SCHMIDT-WOLF (2011)
In Vivo
25, 325-333
|Abstract »|Full Text »|PDF »
Influencing the Wnt Signaling Pathway in Multiple Myeloma.
Y. KIM, G. REIFENBERGER, D. LU, T. ENDO, D. A. CARSON, S.-M. GAST, K. MESCHENMOSER, M. NOWAK, and I. G. H. SCHMIDT-WOLF (2011)
Anticancer Res
31, 725-730
|Abstract »|Full Text »|PDF »
Increased In Vivo Efficacy of Lenalidomide by Addition of Piroctone Olamine.
Y. KIM, P. ALPMANN, S. BLAUM-FEDER, S. KRAMER, T. ENDO, D. LU, D. CARSON, and I. G. H. SCHMIDT-WOLF (2011)
In Vivo
25, 99-103
|Abstract »|Full Text »|PDF »
Evaluation of a chemical library of small-molecule Dishevelled antagonists that suppress tumor growth by down-regulating T-cell factor-mediated transcription.
L. You, Z. Xu, C. Punchihewa, D. M. Jablons, and N. Fujii (2008)
Mol. Cancer Ther.
7, 1633-1638
|Abstract »|Full Text »|PDF »
E.L. Scheller, J. Chang, and C.Y. Wang (2008)
Journal of Dental Research
87, 126-130
|Abstract »|Full Text »|PDF »
Noncanonical Wnt-4 Signaling Enhances Bone Regeneration of Mesenchymal Stem Cells in Craniofacial Defects through Activation of p38 MAPK.
J. Chang, W. Sonoyama, Z. Wang, Q. Jin, C. Zhang, P. H. Krebsbach, W. Giannobile, S. Shi, and C.-Y. Wang (2007)
J. Biol. Chem.
282, 30938-30948
|Abstract »|Full Text »|PDF »
Tbx3 Is a Downstream Target of the Wnt/{beta}-Catenin Pathway and a Critical Mediator of {beta}-Catenin Survival Functions in Liver Cancer.
C.-A. Renard, C. Labalette, C. Armengol, D. Cougot, Y. Wei, S. Cairo, P. Pineau, C. Neuveut, A. de Reynies, A. Dejean, et al. (2007)
Cancer Res.
67, 901-910
|Abstract »|Full Text »|PDF »
Interleukin-17 Receptor-Like Gene Is a Novel Antiapoptotic Gene Highly Expressed in Androgen-Independent Prostate Cancer.
Z. You, X.-B. Shi, G. DuRaine, D. Haudenschild, C. G. Tepper, S. Hao Lo, R. Gandour-Edwards, R. W. de Vere White, and A. H. Reddi (2006)
Cancer Res.
66, 175-183
|Abstract »|Full Text »|PDF »
Wnt5a Expression Is Associated With the Tumor Proliferation and the Stromal Vascular Endothelial Growth Factor--An Expression in Non-Small-Cell Lung Cancer.
C.-l. Huang, D. Liu, J. Nakano, S. Ishikawa, K. Kontani, H. Yokomise, and M. Ueno (2005)
J. Clin. Oncol.
23, 8765-8773
|Abstract »|Full Text »|PDF »
A Human- and Male-Specific Protocadherin that Acts through the Wnt Signaling Pathway to Induce Neuroendocrine Transdifferentiation of Prostate Cancer Cells.
X. Yang, M.-W. Chen, S. Terry, F. Vacherot, D. K. Chopin, D. L. Bemis, J. Kitajewski, M. C. Benson, Y. Guo, and R. Buttyan (2005)
Cancer Res.
65, 5263-5271
|Abstract »|Full Text »|PDF »
Secreted Frizzled-Related Protein 4 Is Silenced by Hypermethylation and Induces Apoptosis in {beta}-Catenin-Deficient Human Mesothelioma Cells.
B. He, A. Y. Lee, S. Dadfarmay, L. You, Z. Xu, N. Reguart, J. Mazieres, I. Mikami, F. McCormick, and D. M. Jablons (2005)
Cancer Res.
65, 743-748
|Abstract »|Full Text »|PDF »
Global Inhibition of Lef1/Tcf-dependent Wnt Signaling at Its Nuclear End Point Abrogates Development in Transgenic Xenopus Embryos.
T. Deroo, T. Denayer, F. Van Roy, and K. Vleminckx (2004)
J. Biol. Chem.
279, 50670-50675
|Abstract »|Full Text »|PDF »
Wnt10b Inhibits Development of White and Brown Adipose Tissues.
K. A. Longo, W. S. Wright, S. Kang, I. Gerin, S.-H. Chiang, P. C. Lucas, M. R. Opp, and O. A. MacDougald (2004)
J. Biol. Chem.
279, 35503-35509
|Abstract »|Full Text »|PDF »
Inhibition of Wnt-1 Signaling Induces Apoptosis in {beta}-Catenin-Deficient Mesothelioma Cells.
L. You, B. He, K. Uematsu, Z. Xu, J. Mazieres, A. Lee, F. McCormick, and D. M. Jablons (2004)
Cancer Res.
64, 3474-3478
|Abstract »|Full Text »|PDF »
EGF receptor signalling protects smooth-cuticle cells from apoptosis during Drosophila ventral epidermis development.
Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization.
M. A. Gregory, Y. Qi, and S. R. Hann (2003)
J. Biol. Chem.
278, 51606-51612
|Abstract »|Full Text »|PDF »
Potential Role of Microsomal Prostaglandin E Synthase-1 in Tumorigenesis.
D. Kamei, M. Murakami, Y. Nakatani, Y. Ishikawa, T. Ishii, and I. Kudo (2003)
J. Biol. Chem.
278, 19396-19405
|Abstract »|Full Text »|PDF »
{beta}-Catenin-related Anomalies in Apoptosis-resistant and Hormone-refractory Prostate Cancer Cells.
A. de la Taille, M. A. Rubin, M.-W. Chen, F. Vacherot, S. G.-D. de Medina, M. Burchardt, R. Buttyan, and D. Chopin (2003)
Clin. Cancer Res.
9, 1801-1807
|Abstract »|Full Text »|PDF »
A {beta}-catenin survival signal is required for normal lobular development in the mammary gland.
S. B. Tepera, P. D. McCrea, and J. M. Rosen (2003)
J. Cell Sci.
116, 1137-1149
|Abstract »|Full Text »|PDF »
Hepatocyte Growth Factor Inhibits Anoikis by Induction of Activator Protein 1-dependent Cyclooxygenase-2. IMPLICATION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA PROGRESSION.
Q. Zeng, L. K. McCauley, and C.-Y. Wang (2002)
J. Biol. Chem.
277, 50137-50142
|Abstract »|Full Text »|PDF »
Wnt Signaling Protects 3T3-L1 Preadipocytes from Apoptosis through Induction of Insulin-like Growth Factors.
K. A. Longo, J. A. Kennell, M. J. Ochocinska, S. E. Ross, W. S. Wright, and O. A. MacDougald (2002)
J. Biol. Chem.
277, 38239-38244
|Abstract »|Full Text »|PDF »